Literature DB >> 35941476

Capillary Electrophoresis-Mass Spectrometry (CE-MS) by Sheath-Flow Nanospray Interface and Its Use in Biopharmaceutical Applications.

Mei Han1, Richard Smith2, Dan A Rock2.   

Abstract

Both capillary electrophoresis (CE) and mass spectrometry (MS) technologies are powerful analytical tools that have been used extensively in the characterization of biologics in the biopharmaceutical industry. The direct coupling of CE with MS is an attractive approach, in that the high separation capability of CE and the ultrasensitive detection and accurate identification performance of MS can be combined to provide a powerful system for the analysis of complex analytes. In this chapter, we discuss the detailed procedure of carrying out CE-MS analysis using a nano sheath-flow interface and its applications including intact mass analysis of monoclonal antibodies and fusion proteins, and a biotransformation study of two Fc-FGF21 molecules in a single-dose pharmacokinetic mice study. Optimization processes, including the finetuning of CE conditions and MS parameters, are illustrated in this chapter, with focuses on method robustness and assay reproducibility.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Affinity capture; Affinity purification; Biotransformation; CE-MS; Capillary electrophoresis–mass spectrometry; FGF21; Fusion protein; Intact mass analysis; Monoclonal antibody; Time-of-flight

Mesh:

Substances:

Year:  2022        PMID: 35941476     DOI: 10.1007/978-1-0716-2493-7_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  31 in total

1.  Optimization and validation of a quantitative capillary electrophoresis sodium dodecyl sulfate method for quality control and stability monitoring of monoclonal antibodies.

Authors:  Oscar Salas-Solano; Brandon Tomlinson; Sarah Du; Monica Parker; Alex Strahan; Stacey Ma
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

Review 2.  Applications of capillary electrophoresis in characterizing recombinant protein therapeutics.

Authors:  Shuai Sherry Zhao; David D Y Chen
Journal:  Electrophoresis       Date:  2013-11-22       Impact factor: 3.535

3.  Biopharmaceutical benchmarks 2018.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

Review 4.  Determination of protein charge variants with (imaged) capillary isoelectric focusing and capillary zone electrophoresis.

Authors:  Julia Kahle; Hermann Wätzig
Journal:  Electrophoresis       Date:  2018-06-19       Impact factor: 3.535

5.  Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis.

Authors:  Jessica S Creamer; Nathan J Oborny; Susan M Lunte
Journal:  Anal Methods       Date:  2014-07-08       Impact factor: 2.896

6.  Applications of imaged capillary isoelectric focussing technique in development of biopharmaceutical glycoprotein-based products.

Authors:  Carrie L Anderson; Yang Wang; Richard R Rustandi
Journal:  Electrophoresis       Date:  2012-06       Impact factor: 3.535

Review 7.  The Increasingly Human and Profitable Monoclonal Antibody Market.

Authors:  António L Grilo; A Mantalaris
Journal:  Trends Biotechnol       Date:  2018-06-23       Impact factor: 19.536

8.  Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo.

Authors:  Mei Han; Josh T Pearson; Yunan Wang; Dwight Winters; Marcus Soto; Dan A Rock; Brooke M Rock
Journal:  Anal Biochem       Date:  2017-10-10       Impact factor: 3.365

Review 9.  Protein post-translational modifications: In silico prediction tools and molecular modeling.

Authors:  Martina Audagnotto; Matteo Dal Peraro
Journal:  Comput Struct Biotechnol J       Date:  2017-03-31       Impact factor: 7.271

Review 10.  Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy.

Authors:  Esteban Cruz; Veysel Kayser
Journal:  Biologics       Date:  2019-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.